Antibiotic Timing in Pediatric Septic Shock

Roni D Lane1, Jared Olson2,3, Ron Reeder4

  • 1Divisions of Pediatric Emergency Medicine, roni.lane@hsc.utah.edu.

Hospital Pediatrics
|March 4, 2020
PubMed

Insights

This study found no link between how quickly children with septic shock received antibiotics and their outcomes. The findings question the strict one-hour benchmark for antibiotic administration in pediatric septic shock cases.

Area of Science:

  • Pediatric Emergency Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • National guidelines recommend antibiotics within 1 hour for pediatric septic shock.
  • Evidence supporting this specific benchmark in pediatric literature is variable.
  • Septic shock involves perfusion issues or hypotension in children.

Purpose of the Study:

  • To examine the association between target time to antibiotic administration (TTAA) and clinical outcomes in children with suspected septic shock.
  • To evaluate mortality, PICU admission, length of stay, and organ dysfunction resolution.
  • To contribute to the understanding of optimal antibiotic timing in pediatric sepsis.

Main Methods:

  • Retrospective study of children (<18 years) treated for septic shock in a pediatric ED.
  • Data collected from February 2007 to December 2015.
  • Multivariable regression models used to assess TTAA associations with outcomes.

Main Results:

  • 1377 patients included; 1.5% mortality.
  • 90% met TTAA goals; 71% received antibiotics within 2 hours.
  • No significant associations found between TTAA and mortality, PICU admission, or length of stay.

Conclusions:

  • The study found no association between TTAA and clinical outcomes in pediatric septic shock.
  • This adds to evidence questioning the strict 1-hour antibiotic administration benchmark.
  • Further research may optimize resource use and reduce unnecessary antibiotic exposure.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
229
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
189
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
202
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
138